OXIDIZED COLLAGEN FORMULA- TIONS FOR USE WITH NONCOMPATIBLE PHARMACEUTICAL AGENTS

Details for Australian Patent Application No. 2002236731 (hide)

Owner MATRIX PHARMACEUTICAL, INC.

Inventors BURKE, David, J.; KUAN, Son, I.

Pub. Number AU-A-2002236731

PCT Pub. Number WO2002/092055

Priority 09/858,247 15.05.01 US

Filing date 17 January 2002

Wipo publication date 25 November 2002

International Classifications

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 038/00 Medicinal preparations containing peptides

A61K 038/17 Medicinal preparations containing peptides - from animals

Event Publications

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002236731

21 April 2005 Change of Name(s) of Applicant(s), Section 104

  BioMedicines, Inc. The name of the applicant has been changed to Intarcia Therapeutics, Inc.

8 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236732-Compositions comprising cyclohexamantane

2002236730-Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-HT6 receptor